×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
The State of Clinical Trials in 2024: Are We Making the Grade?
Session Chair(s)
Summer Starling, DrPH, MPH
Senior Project Manager
Clinical Trials Transformation Initiative (CTTI), United States
This forum will present metrics developed and tested to understand progress for improving trials by 2030. A panel will provide work in areas of metrics for assessing progress in improving trials and understanding the state of clinical trials in 2024.
Learning Objective : Discuss current efforts to establish metrics for assessing progress on efforts to improve trials, including improvements to trial design quality and representativeness of trials; Identify areas of trial improvements that may be measured or assessed; Appraise metrics approaches for relevance to improving specific areas of trial operations.
Speaker(s)
Panelist
Jennifer Miller, PhD
Yale School of Medicine, United States
Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics
Panelist
Linda B Sullivan, MBA
Tufts Center For the Study of Drug Development, United States
Senior Fellow
Have an account?